The disability consultants have received an investment from Mitie's corporate venturing unit which could potentially rise to $13m, in return for a majority stake.

Biopharma company AstraZeneca has increased the capital in its corporate venturing fund to $400m, as it invests in life sciences company NeuProtect.

The life sciences technology company has taken its funding past the $15m mark with mutual insurance firm Sham co-leading the round.

Biopharmaceutical company Zedira has followed up funding from High-Tech Gruenderfonds and R-Biopharm by licensing development of its celiac disease treatment to Dr Falk.

The Evolved Group has picked up investment from St Ives, which has acquired a 15.8% stake in the e-book conversion software developer.

The corporate venturing unit of Germany-based media group Bertelsmann is putting six-figure faith in online ad agency Adspert.

The pricing intelligence service has raised $1m in seed funding from investors including an equity fund belonging to the Bank of Ireland.